share_log

NIO, Lucid Group And Other Big Gainers From Monday

NIO, Lucid Group And Other Big Gainers From Monday

蔚來、Lucid Group等週一起大漲
Benzinga Real-time News ·  2022/09/13 03:01

U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.

美國股市週一收盤走高，道瓊斯指數飆升超過200點。以下是前一交易日走高的一些大型股的名單。

  • Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares climbed 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
  • IHS Holding Limited (NYSE:IHS) gained 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year.
  • Asana, Inc. (NYSE:ASAN) rose 16.4% to close at $28.71. Asana's President, CEO and Director Dustin Moskovitz bought a total of 19,273,127 shares at an average price of $18.16.
  • Carvana Co. (NYSE:CVNA) rose 15.5% to close at $42.28. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73.
  • NIO Inc. (NYSE:NIO) surged 13.5% to close at $21.75 after Deutsche Bank reportedly reiterated the stock as a top China pick.
  • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) rose 12.8% to close at $31.98 after the company announced data from the Phase 3 DeFi trial of nirogacestat in adult patients with desmoid tumors showed nirogacestat treatment resulted in rapid, sustained and statistically significant improvements in primary and all key secondary efficacy endpoints.
  • Sigma Lithium Corporation (NASDAQ:SGML) gained 11.4% to close at $27.81.
  • Montauk Renewables, Inc. (NASDAQ:MNTK) jumped 10.7% to close at $20.16.
  • Lucid Group, Inc. (NASDAQ:LCID) jumped 9.7% to close at $16.55 after RF Lafferty initiated coverage on the stock with a Buy rating and a $19 price target.
  • NetScout Systems, Inc. (NASDAQ:NTCT) rose 9.4% to close at $33.60. The company, last month, posted upbeat quarterly earnings.
  • 5E Advanced Materials Inc. (NASDAQ:FEAM) jumped 9.3% to settle at $18.14.
  • TAL Education Group (NYSE:TAL) gained 9.1% to close at $5.89.
  • Sprinklr, Inc. (NYSE:CXM) jumped 8.1% to close at $13.29 after the company last week reported better-than-expected Q2 results and issued strong guidance.
  • Wayfair Inc. (NYSE:W) gained 7.7% to settle at $55.95 amid overall market strength as investors await this week's inflation data.
  • Bristol-Myers Squibb Company (NYSE:BMY) gained 3.1% to settle at $72.36. The FDA approved Bristol Myers Squibb Co's Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Atlantic Equities maintained Bristol-Myers Squibb with an Overweight and raised the price target from $83 to $87.
  • 文蒂克斯生物科學公司納斯達克(Sequoia Capital：VTYX)股價週一攀升65%，收於38.11美元，此前奧本海默維持對該股的強於大盤的評級，並將目標價從40美元上調至65美元。
  • IHS控股有限公司(紐約證券交易所代碼：IHS)上漲24.9%，收於7.83美元。上個月，IHS Holding表示，第二季度每股收益同比下降。
  • 阿莎娜股份有限公司(紐約證券交易所代碼：ASAN)上漲16.4%，收於28.71美元。阿莎娜的首席執行官總裁和董事首席執行官達斯汀·莫斯科維茨以18.16美元的平均價格購買了19,273,127股票。
  • Carvana Co.(紐約證券交易所代碼：CVNA)上漲15.5%，收於42.28美元。Piper Sandler將Carvana評級從中性上調至增持，並將目標價從98美元下調至73美元。
  • 蔚來。蔚來(NYSE：Tmall)暴漲13.5%，收於21.75美元，此前有報道稱，德意志銀行重申該股為中國首選。
  • SpringWorks治療公司納斯達克(納斯達克股票代碼：SWTX)上漲12.8%，收於31.98美元，此前該公司宣佈，在成年硬纖維瘤患者中進行的尼羅西坦3期DEFI試驗數據顯示，尼羅西坦治療導致主要和所有關鍵次要療效終點的快速、持續和統計上的顯著改善。
  • 西格瑪鋰公司納斯達克(Sequoia Capital：SGML)上漲11.4%，收於27.81美元。
  • 蒙托克可再生能源公司納斯達克(Sequoia Capital：MNTK)跳漲10.7%，收於20.16美元。
  • Lucid Group公司納斯達克(Kleiner Perkins Caufield&Byers)股價上漲9.7%，收於16.55美元，此前RF Lafferty對該股的評級為買入，目標價為19美元。
  • NetScout系統公司納斯達克(Standard Chartered Bank：NTCT)上漲9.4%，收於33.6美元。上個月，該公司公佈了樂觀的季度收益。
  • 5E先進材料公司納斯達克(Sequoia Capital：FEAM)跳漲9.3%，報18.14美元。
  • 好未來(紐約證券交易所代碼：TAL)上漲9.1%，收於5.89美元。
  • 斯普林克勒股份有限公司紐約證券交易所股票代碼：CXM)跳漲8.1%，收於13.29美元，該公司上週公佈的第二季度業績好於預期，併發布了強勁的指引。
  • WayFair Inc.(紐約證券交易所股票代碼：W)上漲7.7%，收於55.95美元，整體市場走強，投資者等待本週的通脹數據。
  • 百時美施貴寶公司(紐約證券交易所代碼：BMY)上漲3.1%，收於72.36美元。FDA批准百時美施貴寶公司的Sotyktu(Deucravisitinib)，一種變構酪氨酸激酶2(TYK2)抑制劑，用於治療中到重度斑塊型牛皮癬，這些牛皮癬適合系統治療或光療。大西洋證券維持百時美施貴寶的增持，並將目標價從83美元上調至87美元。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論